Health Care & Life Sciences » Pharmaceuticals | Petlife Pharmaceuticals Inc.

Petlife Pharmaceuticals Inc. | Income Statement

Fiscal year is September-August. All values USD Thousands.
2013
2014
2015
2016
2017
Cost of Goods Sold (COGS) incl. D&A
-
-
220.70
-
-
Gross Income
-
-
220.70
-
-
SG&A Expense
913.90
1,512.10
1,714.90
3,687.00
22,385.40
EBIT
913.90
1,512.10
1,935.60
3,687.00
22,385.40
Unusual Expense
600.20
-
-
-
481.60
Non Operating Income/Expense
-
-
-
-
6.10
Interest Expense
108.10
-
-
-
383.70
Pretax Income
1,622.30
1,512.10
1,935.60
3,687.00
23,256.90
Consolidated Net Income
1,622.30
1,512.10
1,935.60
3,687.00
23,256.90
Net Income
1,160.80
1,512.10
1,935.60
3,687.00
23,256.90
Net Income After Extraordinaries
1,160.80
1,512.10
1,935.60
3,687.00
23,256.90
Net Income Available to Common
1,160.80
1,512.10
1,935.60
3,687.00
23,256.90
EPS (Basic)
239.00
0.20
0.15
2.00
0.34
Basic Shares Outstanding
4.90
8,022.70
11,459.60
1,824.80
68,805.00
EPS (Diluted)
238.73
0.19
0.17
2.02
0.34
Diluted Shares Outstanding
4.90
8,022.70
11,459.60
1,824.80
68,805.00
EBITDA
913.90
1,512.10
1,935.60
3,687.00
22,385.40
Minority Interest Expense
461.50
-
-
-
-

About Petlife Pharmaceuticals

View Profile
Address
38 West Main Street
Hancock Maryland 21750
United States
Employees -
Website http://www.petlifepharma.com
Updated 07/08/2019
Petlife Pharmaceuticals, Inc. engages in the research, development, sales, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases. Its products include preventative, tabs, and pet foods under the brand name Vitalzul. The company was founded on June 26, 2014 and is headquartered in Hancock, MD.

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.